Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 14 Neoplasm Metastasis 8 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Meningeal Carcinomatosis 1 HER2-mutant Non-Small Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Ipilimumab 98 pembrolizumab 84 Nivolumab 82 aldesleukin 51 Cyclophosphamide 49 Interleukin-2 38 fludarabine phosphate 31 Vemurafenib 31 Dacarbazine 31 dabrafenib 29 trametinib 28 Temozolomide 26 fludarabine 25 CTLA-4 Antigen 18 Bevacizumab 18 Radiosurgery 15 Paclitaxel 15 Carboplatin 14 encorafenib 13 binimetinib 13 Introns 13 talimogene laherparepvec 12 Radiotherapy 12 Interferon alpha-2 12 spartalizumab 11 cobimetinib 10 atezolizumab 10 sargramostim 9 peginterferon alfa-2b 9 montanide ISA 51 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × trastuzumab deruxtecan × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡